Pleasanton-based Juvaris BioTherapeutics Tuesday announced another big shot in the arm from the federal government - a $9 million grant over five years to develop a way to boost the effectiveness of flu vaccines.
Juvaris will split an undetermined portion of the money with researchers at Stanford University and California National Primate Research Center at the University of California-Davis, which will help do research. Their studies will focus on JuvaVax - an adjuvant or vaccine additive Juvaris has developed - which has been shown in initial tests to increase the body's immune response to various kinds of influenza.
The grant was issued by the National Institute of Allergy and Infectious Diseases, which last year awarded Juvaris and Stanford a two-year, $1 million grant to begin work on a vaccine to counter a bird-flu outbreak.
No comments:
Post a Comment